All data are based on the daily closing price as of April 22, 2026
y
Yuhan
000100.KO
64.37 USD
-1.23
-1.87%
Overview
Last close
64.37 usd
Market cap
4.74B usd
52 week high
108.69 usd
52 week low
61.09 usd
Target price
97.22 usd
Valuation
P/E
N/A
Forward P/E
36.63
Price/Sales
3.2499
Price/Book Value
3.1291
Enterprise Value
4.85B usd
EV/Revenue
3.2753
EV/EBITDA
23.3109
Key financials
Revenue TTM
1.48B usd
Gross Profit TTM
493.16M usd
EBITDA TTM
118.10M usd
Earnings per Share
N/A usd
Dividend
0.41 usd
Total assets
2.23B usd
Net debt
N/A usd
About
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and analytical method development and regulatory support. The company also provides APIs and intermediates, including antibiotic, anti-thrombotic, anti-hyperlipidemics, and anti-hypertensive; and custom synthesis services through commercial supply in areas of anti-viral, anti-HIV, anti-HCV, anti-biotic, antihistamine, anti-diabetic, ß-lactamase inhibitor, CNS intermediate, PEG-compounds, and others. Yuhan Corporation was founded in 1926 and is headquartered in Seoul, South Korea.